Genelux GNLX
NASDAQ GNLX
$2.07 -0.43 (-17.20%)
At close: Oct 21, 2026 · 4:00 PM EDT

Genelux (GNLX) Preferred Shares (2022)

Updated

Genelux (GNLX) recorded Preferred Shares of $22,000 in Q4 2022.

Analysis

Genelux (GNLX) Preferred Shares (2022) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Shares (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn -
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn -
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn -
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn -
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn -
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn -
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -
10 Genelux 91.17 Mn 29.45 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 22,000.00
API Access

Genelux Preferred Shares API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-shares&ticker=GNLX&period=max&api_key=YOUR_API_KEY